Leadership appointment

Genflow Biosciences appoints seasoned biotech leader Gad Berdugo as Chairman to accelerate its gene therapy pipeline for age-related diseases. Berdugo’s expertise in RNA-LNP therapeutics and U.S. market expansion is expected to drive strategic growth. Key data readouts in 2026 will be critical under his guidance, with Tamara Joseph continuing on the board for continuity.

LICT Corporation reported its Q2 2025 financial results, with revenue increasing 2% to $34.4 million. Non-regulated revenue grew by 2% to $19.2 million, representing 56% of total revenue. Broadband and voice lines increased due to the acquisition of Manti Telephone Company. EBITDA for the quarter was $13.5 million, a decrease of 4.9% year-over-year. Joe Cecin was appointed as Chief Operating Officer. The company also announced the continuation of its Shareholder Designated Charitable Contribution Program, pending board approval.